Incidence of breast cancer among postmenopausal, hypertensive women

Abstract Elevated blood pressure has been proposed to be a risk factor for breast cancer but the results remain controversial. In this study, the incidence of breast cancer among 9,112 postmenopausal, hypertensive women included in the community‐based hypertension register of the North Karelia proje...

Full description

Bibliographic Details
Published in:International Journal of Cancer
Main Authors: Lindgren, Annamarja, Pukkala, Eero, Tuomilehto, Jaakko, Nissinen, Aulikki
Format: Article in Journal/Newspaper
Language:English
Published: Wiley 2007
Subjects:
Online Access:http://dx.doi.org/10.1002/ijc.22689
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.22689
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.22689
id crwiley:10.1002/ijc.22689
record_format openpolar
spelling crwiley:10.1002/ijc.22689 2024-06-02T08:09:46+00:00 Incidence of breast cancer among postmenopausal, hypertensive women Lindgren, Annamarja Pukkala, Eero Tuomilehto, Jaakko Nissinen, Aulikki 2007 http://dx.doi.org/10.1002/ijc.22689 https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.22689 https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.22689 en eng Wiley http://onlinelibrary.wiley.com/termsAndConditions#vor International Journal of Cancer volume 121, issue 3, page 641-644 ISSN 0020-7136 1097-0215 journal-article 2007 crwiley https://doi.org/10.1002/ijc.22689 2024-05-03T11:32:21Z Abstract Elevated blood pressure has been proposed to be a risk factor for breast cancer but the results remain controversial. In this study, the incidence of breast cancer among 9,112 postmenopausal, hypertensive women included in the community‐based hypertension register of the North Karelia project was assessed through the Finnish Cancer Registry. The mean follow‐up time was 27 years. The incidence of breast cancer in hypertensive women in our cohort was similar to the age and period specific population‐based rates for Eastern Finland [the standardised incidence ratio 0.96 (95% confidence interval 0.86–1.05)]. In the Cox regression analysis, there was no association between blood pressure levels, or use of antihypertensive (AH) drugs, and breast cancer incidence, when all women were considered. There was a statistically significant interaction of the use of AH drugs at baseline and the diastolic blood pressure (DBP). Among women who were not using AH drugs at baseline, the DBP level was positively associated with the subsequent risk of breast cancer (hazard ratio 1.26/10 mm Hg, 95% confidence interval 1.06–1.46). In women with AH drugs at baseline, the DBP had an opposite effect of borderline significance (hazard ratio 0.90/10 mm Hg, 95% confidence interval 0.78–1.01). In conclusion, breast cancer incidence among postmenopausal hypertensive patients in general does not differ from that of general population. Elevated DBP levels may be associated with an increased breast cancer risk among nonpharmacologically treated women. © 2007 Wiley‐Liss, Inc. Article in Journal/Newspaper karelia* Wiley Online Library International Journal of Cancer 121 3 641 644
institution Open Polar
collection Wiley Online Library
op_collection_id crwiley
language English
description Abstract Elevated blood pressure has been proposed to be a risk factor for breast cancer but the results remain controversial. In this study, the incidence of breast cancer among 9,112 postmenopausal, hypertensive women included in the community‐based hypertension register of the North Karelia project was assessed through the Finnish Cancer Registry. The mean follow‐up time was 27 years. The incidence of breast cancer in hypertensive women in our cohort was similar to the age and period specific population‐based rates for Eastern Finland [the standardised incidence ratio 0.96 (95% confidence interval 0.86–1.05)]. In the Cox regression analysis, there was no association between blood pressure levels, or use of antihypertensive (AH) drugs, and breast cancer incidence, when all women were considered. There was a statistically significant interaction of the use of AH drugs at baseline and the diastolic blood pressure (DBP). Among women who were not using AH drugs at baseline, the DBP level was positively associated with the subsequent risk of breast cancer (hazard ratio 1.26/10 mm Hg, 95% confidence interval 1.06–1.46). In women with AH drugs at baseline, the DBP had an opposite effect of borderline significance (hazard ratio 0.90/10 mm Hg, 95% confidence interval 0.78–1.01). In conclusion, breast cancer incidence among postmenopausal hypertensive patients in general does not differ from that of general population. Elevated DBP levels may be associated with an increased breast cancer risk among nonpharmacologically treated women. © 2007 Wiley‐Liss, Inc.
format Article in Journal/Newspaper
author Lindgren, Annamarja
Pukkala, Eero
Tuomilehto, Jaakko
Nissinen, Aulikki
spellingShingle Lindgren, Annamarja
Pukkala, Eero
Tuomilehto, Jaakko
Nissinen, Aulikki
Incidence of breast cancer among postmenopausal, hypertensive women
author_facet Lindgren, Annamarja
Pukkala, Eero
Tuomilehto, Jaakko
Nissinen, Aulikki
author_sort Lindgren, Annamarja
title Incidence of breast cancer among postmenopausal, hypertensive women
title_short Incidence of breast cancer among postmenopausal, hypertensive women
title_full Incidence of breast cancer among postmenopausal, hypertensive women
title_fullStr Incidence of breast cancer among postmenopausal, hypertensive women
title_full_unstemmed Incidence of breast cancer among postmenopausal, hypertensive women
title_sort incidence of breast cancer among postmenopausal, hypertensive women
publisher Wiley
publishDate 2007
url http://dx.doi.org/10.1002/ijc.22689
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.22689
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.22689
genre karelia*
genre_facet karelia*
op_source International Journal of Cancer
volume 121, issue 3, page 641-644
ISSN 0020-7136 1097-0215
op_rights http://onlinelibrary.wiley.com/termsAndConditions#vor
op_doi https://doi.org/10.1002/ijc.22689
container_title International Journal of Cancer
container_volume 121
container_issue 3
container_start_page 641
op_container_end_page 644
_version_ 1800755540548124672